Summary
This 8-K filing from BeOne Medicines Ltd. (ONC), dated February 27, 2019, primarily serves to announce the company's financial results for the fourth quarter and full year ended December 31, 2018. The filing incorporates by reference a press release (Exhibit 99.1) detailing these financial results and a presentation (Exhibit 99.2) to be shared at investor events. Investors should note that while the filing discloses financial performance and business updates, much of the detailed information is contained within the attached exhibits, which are furnished rather than formally filed under certain SEC provisions.
Key Highlights
- 1Announcement of Q4 and Full Year 2018 financial results.
- 2Disclosure of financial condition and results of operations for the period ended December 31, 2018.
- 3Company scheduled investor events, including a conference call/webcast and an in-person event in Hong Kong, to discuss the results.
- 4Incorporation of a press release (Exhibit 99.1) detailing financial outcomes.
- 5Incorporation of an investor presentation (Exhibit 99.2) outlining business highlights and future milestones.
- 6Updates on recent business highlights and expected milestones for 2019 provided in the press release.